Published Healthcare & Pharmaceuticals Bioactive Compounds for COVID University of Arizona inventors have developed bioactive compound inhibitors for targeting the SARS-CoV-2 main protease. By The University of Arizona
Published Healthcare & Pharmaceuticals Image-Based COVID Screening This invention is a rapid image-based drug screening software platform for bioactive compounds that can block SARS-CoV-2 replication cycles. By The University of Arizona
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
